Continuing Legal Education (CLE)
In This Section
AIPLA CLE Webinar: Global FRAND Licensing in the Digital Era: Negotiation, Disputes, Remedies, and Resolutions Across Jurisdictions
March 9, 2022 12:30 PM to 2:00 PM
Credits
1.5 CLE Credits Available
Registration
This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. To select the free (no CLE) option, choose the "Registrant_No_CLE" registrant type on the registration page.
Presented by: Takanori ABE of ABE & Partners; Eeva Hakoranta of InterDigital; Dr. Clemens-August Heusch of Nokia Solutions and Networks GmbH & Co KG; Jane Mutimear of Bird & Bird (UK); and moderated by Pat Breslin of Breslin Consulting, LLC
This event is free to AIPLA members who are not requesting CLE. Standard webinar pricing applies to those requesting CLE. CLE is included for our All Access Pass holders and Corporate Subscribers.
Pricing below only applies to those requesting CLE

In response to Covid-19, AIPLA has put in-place a new process for Multiple Attendee Site registrations that allows each site registrant to participate in the webinar independently.
Special rate for AIPLA SOLO PRACTICE/SMALL FIRM MEMBERS: $65
Special rate for AIPLA STUDENT MEMBERS: $10
Registration includes:
- For multiple-attendee sites, each registered participant will receive individual logins due to Covid-19 social distancing requirements.
- CLE certification/processing for applicable states. Reference CLE Information below for complete details.
- Webinar materials, including complete CLE processing information, accessible 24-48 hours before webinar date.
Cancellation Policy:
To get full refund, registrant must request refund five (5) days prior to live event. If less than five (5) days, registrant is transferred to product.
System requirements:
Webinar access is compatible with any Windows 7 or later computer, Android OS devices, or Apple/iOS devices. Check system compatibility here.
Accessibility for hearing impaired:
AIPLA’s webinars are available and accessible to individuals who are hearing impaired. If anyone at your location would like to know more about accommodations, please contact cle@aipla.org. We ask that you let us know at least 7 business days out from the webinar, to ensure that we can identify and deploy the solution that best fits our registrants needs.
CLE INFORMATION
AIPLA is a pre-approved CLE provider with the following states:
- Alaska
- California
- New Hampshire
- New Mexico
- New York
- Pennsylvania
- Vermont
AIPLA has applied for CLE accreditation in the following states:
- Alabama
- Florida
- Illinois
- Indiana
- Minnesota
- Ohio
- Tennessee
- Texas
- Virginia
- Washington
CLE Restrictions:
ATTENTION attorneys in Louisiana, Ohio, Pennsylvania and Utah
These states mandate attorneys can only view a webinar independently at their own computer to receive CLE credit. Multiple attendees prohibited.
ATTENTION attorneys in Arizona
Arizona does not certify courses or providers. Arizona lawyers are required to independently review AZ's regulations and make their own determination that it qualifies for credit towards their MCLE requirements. MCLE Regulation 104(A) identifies the standards to apply. AIPLA will email an attendance affidavit to registrants requesting AZ CLE credit after the webinar.
ATTENTION attorneys in New Hampshire
New Hampshire attendees must self-determine whether a program is eligible for credit, and self-report their attendance according to NH Supreme Court Rule 53. The New Hampshire Minimum Continuing Legal Education (NHMCLE) Board does not approve or accredit CLE activities for the NH Minimum CLE requirement. AIPLA will email an attendance affidavit to registrants requesting NH CLE credit after the webinar.
Disclaimer: AIPLA is a nonprofit national bar association. The sole purpose of this CLE program is to provide educational and informational content. AIPLA does not provide legal services or advice. The opinions, views and other statements expressed by contributors to this CLE program are solely those of the contributors. These opinions, views and statements of the contributors do not necessarily represent those of AIPLA and should not be construed as such.
News
-
AIPLA Files an Amicus Brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation
March 6, 2023
Arlington, VA. March 6, 2023 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief with the Court of Appeals of Virginia in Pegasystems Inc. v. Appian Corporation, an appeal arising from a $2.1 billion verdict and resulting judgment in a trade secret misappropriation case brought by Appian against Pegasystems. -
AIPLA Comments on Joint USPTO-FDA Collaboration Initiatives
February 28, 2023
Arlington, VA. February 28, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office (USPTO) in response to the USPTO’s Request for Comments on Joint USPTO-FDA Collaboration Initiatives. -
AIPLA Files an Amicus Brief at the Supreme Court in Amgen v. Sanofi
February 14, 2023
Arlington, VA. February 14, 2023 - The American Intellectual Property Law Association (AIPLA) filed an amicus brief at the Supreme Court in Amgen v. Sanofi. -
AIPLA Comments on USPTO Initiatives to Ensure the Robustness and Reliability of Patent Rights
February 8, 2023
Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office’s ("The Office”) Request for Comments on possible initiatives of the Office to ensure the robustness and reliability of patent rights. -
AIPLA Comments on Joint Study on Non-Fungible Tokens (NFTs) and Intellectual Property
February 8, 2023
Arlington, VA. February 8, 2023 - The American Intellectual Property Law Association (AIPLA) submitted comments to the United States Patent and Trademark Office and the United States Copyright Office in response to their joint study on the issues of intellectual property law and policy associated with non-fungible tokens (NFTs).